Hjem › Hjerteanfald › Georgia
Hjerteanfald kliniske forsøg i Georgia
3 studier for Hjerteanfald søger deltagere på steder i Georgia.
Officiel studietekst (engelsk)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Coastal Medical Research, LLC, Brunswick
- Renal Associates LLC, Columbus
- National Clinical Trials, Cordele
- og 2 flere
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Emory University, Atlanta
- Cardiovascular Consultants of S GA, Thomasville
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 4. sep. 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Emory University Hospital, Atlanta
- East Coast Institute for Research, Canton
- Northeast Georgia Medical Center Wisteria Building, Cumming
- og 3 flere
RekruttererFase 3
Alder 50 til 105 · Alle køn · Opdateret 21. aug. 2026 · NCT07136012Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.